Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
Intranasal administration of two doses of the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology was followed by rises in the level of neutralizing secretory influenza antibodies in 82% of the cases. The concomitant study of secretory antibody, IgA and total protein levels, as well as of the serum HAI influenza antibodies demonstrated that their evolution was parallel only in 23% of the vaccinees. The percentage of secretory antibody conversion was similar to the rate of protection conferred by the vaccine.
D000281:Administration, Intranasal; D000914:Antibodies, Viral / Q000032:analysis*; D000917:Antibody Formation; D001798:Blood Proteins / Q000032:analysis; D006801:Humans; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000378:metabolism*; D007071:Immunoglobulin A, Secretory / Q000378:metabolism*; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology* / Q000517:prevention & control; D009305:Nasopharynx / Q000032:analysis / Q000276:immunology
D000914:Antibodies, Viral; D001798:Blood Proteins; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007252:Influenza Vaccines